Media Registration is Open for the BIO CEO and Investor Conference.
Share:
Press Release Summary:
Twelfth Bio CEO & Investor Conference offers forum for discussing investment trends, conducting company presentations and one-on-one meetings, as well as learning about investment opportunities within biotechnology industry. This annual conference for life sciences industry will take place February 8-9 in NYC and feature therapeutic panel discussions as well as roundtable discussions on business trends designed to address issues relevant for investors.
Original Press Release:
Media Registration for Twelfth Annual BIO CEO & Investor Conference Now Available Online
WASHINGTON, D.C. - The Biotechnology Industry Organization (BIO) today announced the opening of media registration for the BIO CEO & Investor Conference. Now in its twelfth year, the BIO CEO & Investor Conference is the largest independent investor conference focused on biotechnology. The conference provides a forum for public and private investors, research analysts, investment bankers and senior-level industry executives to discuss investment trends, conduct company presentations and one-on-one meetings, and learn about investment opportunities within the biotechnology industry.
The annual investor conference for the life sciences industry will take place Feb. 8-9, 2010 at the Waldorf=Astoria Hotel in New York City. The conference will feature therapeutic panel discussions and roundtable discussions on business trends designed to address issues relevant for investors.
"The quality and number of companies that participate, as well as the strength of the sessions that focus on new developments in important therapeutic areas make BIO's CEO & Investor Conference a 'can't miss' event for investors and leading companies in the life sciences industry," said Jim Greenwood, president and CEO of BIO. "The CEO & Investor Conference will help investors identify the latest trends and provide biotech innovators an opportunity to secure the funding necessary to bring their therapeutics to market."
This year's conference will feature corporate presentations from more than 100 hundred companies, 5 workshops featuring leading experts on specific therapeutic and technology topics, seven roundtable sessions, and plenary sessions on timely business issues and industry trends, many opportunities to schedule one-on-one meetings, as well as numerous networking opportunities. The conference is designed to foster an informative dialogue between institutional investors and senior biotechnology executives about emerging and current investment opportunities.
For more information on the BIO CEO & Investor Conference, including registration, hotel accommodations and an up-to-date program, please visit the conference website at ceo.bio.org/opencms/ceo/2008/index.jsp. Advance media registration is available at https://www.compusystems.com/servlet/AttendeeRegLoginServlet?evt_uid=172&site=MEDIA.
Upcoming BIO Events
7th Annual BIO Asia Partnering Conference
January 25-26, 2010
Tokyo, Japan
12th Annual BIO CEO & Investor Conference
February 8-9, 2010
New York, NY
9th Annual Windhover & Windhover PSO
February 23-25, 2010
New York City, NY
BIO-Europe Spring
March 8-10, 2010
Barcelona, Spain
BIO Intellectual Property Counsels Spring Conference and Committee Meeting
April 19-21, 2010
New Orleans, LA
BIO International Convention
May 3-6, 2010
Chicago, IL
McCormick Place Convention Center
2010 BIO Human Resources Conference
May 4-7, 2010
Chicago, IL
About BIO
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.
